Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with …

According to the current clinical practice guidelines for chronic obstructive pulmonary
disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β 2 agonist …

Inhaled corticosteroids (ICS) combined with bronchodilators can reduce the frequency of
exacerbations in some patients with chronic obstructive pulmonary disease (COPD). There …

Background There is controversy regarding the role of blood eosinophil levels as a
biomarker of exacerbation risk in chronic obstructive pulmonary disease (COPD). Our aim …

The high prevalence of COPD together with its high level of misdiagnosis and late diagnosis
dictate the necessity for the development and implementation of clinical practice guidelines …

Background Insufficient epidemiological data are available on bronchiectasis in southern
European populations. The aim of this study was to determine the prevalence and incidence …

Background The high prevalence of COPD in the Russian Federation has been
demonstrated in several epidemiological studies. However, there are still no data on the …

Background Recent data from real world clinical practices on the use of Triple Therapy (TT)
in patients with COPD are scarce. Methods Observational population-based study with …

Background Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

Background Limited information is available regarding medication use in COPD patients
from Latin America. This study evaluated the type of medication used and the adherence to …